The progression of cell death affects the rejection of allogeneic tumors in immune-competent mice – implications for cancer therapy

Large amounts of dead and dying cells are produced during cancer therapy and allograft rejection. Depending on the death pathway and stimuli involved, dying cells exhibit diverse features resulting in defined physiological consequences for the host. It is not fully understood how dying and dead cell...

Full description

Bibliographic Details
Main Authors: Ricardo Alfredo Chaurio, Luis Enrique Munoz, Christian eMaueröder, Christina eJanko, Thomas eHarrer, Barbara eFürnrohr, Michael eNiederweis, Rostyslav eBilyy, Georg eSchett, Martin eHerrmann, Christian eBerens
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00560/full